author-photo

Rao Prabhala

Harvard University
VA Boston Healthcare System

116

Papers

2248

Citations

Citation Trend

Filter By

Papers (116) Sort By

Journal Conference Others

Gabarap Loss Mediates Immune Escape in High Risk Multiple Myeloma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma.

2021
Show All
- Source
- Cite
- Save
Citations (0)
CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways.

2021 Oncotarget
Show All
- Source
- Cite
- Save
Citations (0)
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (23)
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation

2021
Show All
- Source
- Cite
- Save
Citations (6)
P-003: Improving NK cell function in Multiple Myeloma with NKTR-255, a novel polymer-conjugated human IL-15

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
OAB-033: Loss-of-function of GABARAP drives tumor resistance to bortezomib-induced immunogenic cell death in multiple myeloma

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.

2021 Blood Cancer Journal
Show All
- Source
- Cite
- Save
Citations (0)
Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)